Gordon Duff

Last updated

Naida Margaret
​
(m. 1969)​
Sir Gordon Duff
FRCP FMedSci FRSE
Principal of St Hilda's College, Oxford
In office
2014–2021
ChildrenTwo
Education Perth Academy
Hipperholme Grammar School
Alma mater St Peter's College, Oxford
University of London

Sir Gordon William Duff, FRCP , FMedSci , FRSE (born 27 December 1947) is a British medical scientist and academic. He was principal of St Hilda's College, Oxford, from 2014 to 2021. He was Lord Florey Professor of Molecular Medicine at the University of Sheffield from 1991 to 2014.

Contents

Early life and education

Sir Gordon was born on 27 December 1947. [1] He was educated at Perth Academy, then a state grammar school in Perth, Scotland, and at Hipperholme Grammar School, a school in Hipperholme, Yorkshire, England. [1] He studied medicine at St Peter's College, Oxford, graduating with a Bachelor of Arts (BA) degree in 1969 and Bachelor of Medicine and Bachelor of Surgery (BM BCh) degrees in 1975: as per tradition, his BA was promoted to a Master of Arts (MA Oxon) degree in 1975. [1] [2]

He undertook postgraduate research in neuropharmacology at St Thomas's Hospital Medical School, University of London, completing his Doctor of Philosophy (PhD) degree in 1980. [1] [2] His doctoral thesis was titled "Some observations on body temperature regulation in the rabbit". [3] Following postgraduate training at the Royal Postgraduate Medical School, Hammersmith Hospital, he held junior faculty posts at Yale Medical School (Infectious Diseases and Pathology department), and the Howard Hughes Institute of Molecular Immunology at Yale.

Career

From 1975 to 1976, Sir Gordon was a house officer in medicine at St Thomas' Hospital, London, and in surgery at Stracathro Hospital, Angus, Scotland. [1]

He joined Edinburgh Medical School in 1984, heading the Molecular Immunology Group, and in 1990 became the inaugural Florey Professor of Medicine at the University of Sheffield, where he went on to become Faculty Research Dean, Member of the University Council, and Director of the Division of Genomic Medicine.

From January 2013 to 2014, he served as the Chairman of the Medicines and Healthcare products Regulatory Agency. [4] He stepped down in 2014, [5] and was succeeded by Sir Michael Rawlins. [6]

Sir Gordon was the Principal of St Hilda's College, Oxford, from 2014 to 2021. [7] [8] He was the first male head of the formerly all-female college. [9] Since 1 July 2015, he has also been the Chair of the Biotechnology and Biological Sciences Research Council (BBSRC). [10] Sir Gordon has served as a Pro-Vice Chancellor of the University of Oxford, as Board Member of Oxford University's Medical Sciences Division, and is an Honorary Fellow of both St Peter's College and St Hilda's College, Oxford.

He is a Board member of the UK's Foundation for Science and Technology, the Advisory Board of Penn University's Institute For Translational Medicine and Therapeutics (ITMAT), and the Translational Medicine Board at University of British Columbia, Vancouver.

Sir Gordon is now President of the "United In Diversity Foundation", which is focused on implementing the UN's Sustainable Development Goals; a Senior Research Fellow of Nuffield Orthopaedic Centre (Oxford Medical School), co-founder of Sitokine Ltd, and Chair of the International Scientific Advisory Board of Silence Therapeutics.

Honours and awards

In 1999, Duff was elected a Fellow of the Academy of Medical Sciences (FMedSci). [11] In 2008, he was elected a Fellow of the Royal Society of Edinburgh (FRSE). [12] On 17 July 2017, he was awarded an honorary degree by the University of Sheffield. [13] [14]

In the 2007 New Year Honours, he was appointed a Knight Bachelor, and therefore granted the title Sir, "for services to Public Health". [15] This was in recognition of his inquiry into, and report on, the conduct of a Theralizumab clinical trial at Northwick Park Hospital in March 2006. [16]

Sir Gordon was listed in the Science Council’s “Top 100 working scientists in the UK” in 2014. In 2016 he was awarded the Sir James Black Award from the British Pharmacological Society for his paper on “The Original Identification of Tumour Necrosis Factor (TNF) as a Therapeutic Target in Human Arthritis”.

He is a former President of the International Cytokine Society and has received honorary doctorates from the Universities of Edinburgh and Sheffield. He was a co-founding editor of the international research journal ‘SITOKINE’, and advisory editor to the Human Genome Organisation (HUGO) Journal. His identification of the term “cytokine storm” has led to its widespread use when discussing adverse side-effects of influenza-like diseases including COVID-19.

He has given the Croonian Lecture at the Royal College of Physicians of London, the Weatherall Lecture at the University of Oxford, the Harry Bostrom Medal Lecture at Karolinska Institute, and the Faculty Lecture at University of Geneva.

Sir Gordon has lectured extensively at international universities, professional societies and government agencies, including National Institutes of Health (USA), the US Food & Drug Administration, the National Cancer Institute (USA), Institut Pasteur (France), Biopolis (Singapore), the Paul Ehrlich Institute (Germany), the Sanger Centre (Cambridge, UK), and Trinity College, Dublin (Ireland).

Advisory and leadership roles

Sir Gordon has served on many scientific advisory boards and funding panels in the UK, EU and US, including on Government Foresight Groups for the Medical Research Council and the Engineering and Physical Sciences Research Council, and the Wellcome Trust in the UK.

Previously chair of the UK’s Committee on Safety of Medicines (and of its Biological and Vaccines Sub-Committee), he was inaugural chair of the UK's Commission on Human Medicines (CHM, 2005-2012) before becoming chair of the Medicines and Healthcare products Regulatory Agency (the national regulator of all UK medicines and medical devices).

Sir Gordon was chair of the Secretary-of-State's "Expert Scientific Group on Phase One Clinical Trials" following the Northwick Park clinical trial disaster in 2006 involving the drug TGN1412; the report made 22 recommendations to improve the safety of “first-in-human” clinical trials.

From 2002 to 2009 he was chair of the UK's National Biological Standards Board, overseeing the National Institute for Biological Standards and Control (NIBSC, WHO Centre); his responsibilities including setting up the National Stem Cell Bank, vCJD reagent repository and supplying about 95% of the world's biological standards for diagnostics, biological medicines and vaccines.

He was an advisor on biological medicines to the EU, and was chair of the UK's Scientific Pandemic Influenza (SPI) Advisory Committee from 2006-2010. In 2009-2010 he co-chaired the UK government's Scientific Advisory Group for Emergencies (SAGE) to tackle the H1N1 swine flu pandemic; during his tenure he presided over the accelerated procurement and distribution of antivirals, the approval of a specific vaccine, and the establishment of a clinical data group. In 2010 he reviewed the UK's Organ Donor Register, correcting various coding errors to improve reliability.

From 2015 to 2019, Sir Gordon was chair of the UK's Biotechnology and Biological Sciences Research Council (BBSRC) during the launch of the new Pirbright Institute for Animal Health. He chaired the Academic Health Science Centres of Imperial College London (2012-2016) and Trinity College, Dublin (2013-2020), and the MRC/NIHR National Phenome Centre at Imperial.

Publications

With interests in inflammation, immunology, cytokines, therapeutics, biomedicine, public health and genetics, Sir Gordon has published over 400 research articles and government reports on medicines, vaccines and public health. He is co-inventor of around 35 biotech and diagnostic patents.

Personal life

In 1969, Duff married Naida Margaret Clarke, the daughter of Air Commodore Charles Clarke and Eileen Clarke. [17] They have two daughters. [1]

Selected works

A fuller bibliography can be found here: https://scholar.google.co.uk/citations?user=RPEVbnQAAAAJ&hl=en

Related Research Articles

Sir Richard Brook Sykes is a British microbiologist, the chair of the Royal Institution, the UK Stem Cell Foundation, and the trustees at King Edward VII's Hospital, and chancellor of Brunel University. As of June 2021, he is chair of the UK's Vaccine Taskforce, where he is responsible for overseeing the delivery of the COVID-19 vaccination programme, including preparations for booster programmes and encouraging vaccine innovation in the UK.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation, is a non-departmental public body (NDPB), and is the largest UK public funder of non-medical bioscience. It predominantly funds scientific research institutes and university research departments in the UK.

<span class="mw-page-title-main">Lister Institute of Preventive Medicine</span>

The Lister Institute of Preventive Medicine, informally known as the Lister Institute, was established as a research institute in 1891, with bacteriologist Marc Armand Ruffer as its first director, using a grant of £250,000 from Edward Cecil Guinness of the Guinness family. It had premises in Chelsea in London, Sudbury in Suffolk, and Elstree in Hertfordshire, England. It was the first medical research charity in the United Kingdom. It was renamed the Jenner Institute in 1898 and then, in 1903, as the Lister Institute in honour of the great surgeon and medical pioneer, Dr Joseph Lister. In 1905, the institute became a school of the University of London.

Sir Kurt George Matthew Mayer Alberti, is a British doctor. His long-standing special interest is diabetes mellitus, in connection with which he has published many research papers and served on many national and international committees. He was President of the European Association for the Study of Diabetes (EASD) and President of the International Diabetes Federation (IDF). In the 1970s, Alberti published recommendations for the management of diabetic ketoacidosis, a serious metabolic emergency which affects people suffering from severe insulin deficiency. This 'Alberti regime' rationalised the use of insulin and fluid therapy in this condition to the undoubted benefit of many patients.

Sir David Keith Peters is a retired Welsh physician and academic. He was Regius Professor of Physic at the University of Cambridge from 1987 to 2005, where he was also head of the School of Clinical Medicine.

Susan Fiona Dorinthea Michie is a British academic, clinical psychologist, and professor of health psychology, director of The Centre for Behaviour Change and head of The Health Psychology Research Group, all at University College London. She is also an advisor to the British Government via the SAGE advisory group on matters concerning behavioural compliance with government regulations during the COVID-19 pandemic. In 2022, she was appointed Chair of the World Health Organisation’s (WHO) Technical Advisory Group on Behavioural Insights and Sciences for Health.

<span class="mw-page-title-main">Leszek Borysiewicz</span> British immunologist

Sir Leszek Krzysztof Borysiewicz is a British professor, immunologist and scientific administrator. He served as the 345th Vice-Chancellor of the University of Cambridge, his term of office started on 1 October 2010 and ended on 1 October 2017. Borysiewicz also served as chief executive of the Medical Research Council of the UK from 2007-2010 and was the chairman of Cancer Research UK from 2016 to 2023.

Sir John Stewart Savill, FRS, FMedSci is the Chief Executive of the Medical Research Council (MRC) in the UK and the Head of the College of Medicine and Veterinary Medicine and a Vice Principal of the University of Edinburgh.

Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.

Sir Peter Julius Lachmann was a British immunologist, specialising in the study of the complement system. He was emeritus Sheila Joan Smith Professor of Immunology at the University of Cambridge, a fellow of Christ's College, Cambridge and honorary fellow of Trinity College, Cambridge and of Imperial College. He was knighted for service to medical science in 2002.

<span class="mw-page-title-main">Michael Rawlins</span> British clinical pharmacologist (1941–2023)

Sir Michael David Rawlins was a British clinical pharmacologist and emeritus professor at the University of Newcastle upon Tyne. During his medical career he chaired several executive agencies including the Committee on Safety of Medicines from 1993 to 1998, followed by the National Institute for Health and Care Excellence (NICE) for 14 years from its formation in 1999 and then the Medicines and Healthcare products Regulatory Agency (MHRA) for six years from 2014. From 2012 to 2014 he was president of the Royal Society of Medicine.

<span class="mw-page-title-main">Jeremy Farrar</span> British medical researcher

Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.

<span class="mw-page-title-main">James Naismith (chemist)</span> British structural biologist

James Henderson Naismith is Professor of Structural Biology at the University of Oxford, former Director of the Research Complex at Harwell and Director of the Rosalind Franklin Institute. He previously served as Bishop Wardlaw Professor of Chemical Biology at the University of St Andrews. He was a member of Council of the Royal Society (2021-2022). He is currently the Vice-Chair of Council of the European X-ray Free Electron Laser and Vice-President (non-clinical) of The Academy of Medical Sciences. It has been announced that he will be the Head of the MPLS division at Oxford in the autumn of 2023.

Dame Moira Katherine Brigid Whyte FERS is a Scottish physician and medical researcher who is the Sir John Crofton Professor of Respiratory Medicine at the University of Edinburgh. She was the Director the Medical Research Council Centre for Inflammation Research and was Vice-Principal and Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh. Whyte is also a trustee of Cancer Research UK.

Sir Alasdair Muir Breckenridge, was a Scottish pharmacologist.

<span class="mw-page-title-main">Jonathan Friedland</span> British physician and medical researcher

Professor Jonathan Samuel Friedland is a British physician and medical researcher who is Deputy Vice-Chancellor and Professor of Infectious Diseases at St George's, University of London.

The Scientific Advisory Group for Emergencies (SAGE) is a British Government body that advises central government in emergencies. It is usually chaired by the United Kingdom's Chief Scientific Adviser. Specialists from academia and industry, along with experts from within government, make up the participation, which will vary depending on the emergency. SAGE gained public prominence for its role in the 2020 COVID-19 pandemic in the United Kingdom.

<span class="mw-page-title-main">Jonathan Van-Tam</span> British public health physician

Sir Jonathan Stafford Nguyen Van-Tam is a British physician specialising in influenza, including its epidemiology, transmission, vaccinology, antiviral drugs and pandemic preparedness.

Sir Andrew John Pollard is the Ashall Professor of Infection & Immunity at the University of Oxford and a Fellow of St Cross College, Oxford. He is an Honorary Consultant Paediatrician at John Radcliffe Hospital and the Director of the Oxford Vaccine Group. He is the Chief Investigator on the University of Oxford COVID-19 Vaccine trials and has led research on vaccines for many life-threatening infectious diseases including typhoid fever, Neisseria meningitidis, Haemophilus influenzae type b, streptococcus pneumoniae, pertussis, influenza, rabies, and Ebola.

References

  1. 1 2 3 4 5 6 "Duff, Sir Gordon (William)". Who's Who 2018 . Oxford University Press. 1 December 2017. doi:10.1093/ww/9780199540884.013.43452.{{cite web}}: Missing or empty |url= (help)
  2. 1 2 "Professor Sir Gordon Duff". St Hilda's College. University of Oxford. 5 February 2016. Archived from the original on 21 March 2018. Retrieved 20 March 2018.
  3. ↑ Duff, G. W. (1980). Some observations on body temperature regulation in the rabbit. E-Thesis Online Service (Ph.D). The British Library Board. Retrieved 20 March 2018.
  4. ↑ "MHRA chairman steps down – PMLiVE" . Retrieved 2 May 2015.
  5. ↑ "MHRA chairman steps down". PMLive. 2 April 2014. Retrieved 20 March 2018.
  6. ↑ "Sir Michael Rawlins – Government of the United Kingdom" . Retrieved 2 May 2015.
  7. ↑ "Professor Sir Gordon Duff to be next Principal of St Hilda’s College", St Hilda's College, 10 March 2014 Archived 25 March 2014 at the Wayback Machine Accessed 13 March 2014
  8. ↑ "Dr Georgina Paul will be Acting Principal of St Hilda's College 1 April 2021 - 31 January 2022". St Hilda's College, Oxford. Archived from the original on 20 August 2023. Retrieved 3 October 2021.
  9. ↑ Gibbons, Megan (14 March 2014). "St Hilda's elect first ever male Principal". Cherwell . Retrieved 20 March 2018.
  10. ↑ "New chair of the Biotechnology and Biological Sciences Research Council appointed – Government of the United Kingdom". Government of the United Kingdom. 26 March 2015. Retrieved 20 March 2018.
  11. ↑ "Fellow – Sir Gordon Duff FRSE FMedSci". The Academy of Medical Sciences. Retrieved 20 March 2018.
  12. ↑ "Professor Sir Gordon Duff FRSE, FMedSci". The Royal Society of Edinburgh. Retrieved 20 March 2018.
  13. ↑ "Former astronaut and first Briton in space honoured by the University of Sheffield". The University of Sheffield. 12 July 2017. Archived from the original on 1 March 2021. Retrieved 20 March 2018.
  14. ↑ "Professor Sir Gordon Duff receives an Honorary Degree from the University of Sheffield". St Hilda's College. University of Oxford. 17 July 2017. Retrieved 20 March 2018.
  15. ↑ "No. 58196". The London Gazette (Supplement). 30 December 2006. p. 1.
  16. ↑ "Drug trial safety expert knighted". BBC News. 29 December 2006. Retrieved 20 March 2018.
  17. ↑ Telegraph announcements 13 February 2012. Accessed 13 March 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.